Once‐daily long‐acting beta₂‐agonists/inhaled corticosteroids combined inhalers versus inhaled long‐acting muscarinic antagonists for people with chronic obstructive pulmonary disease

BACKGROUND: Three classes of inhaler medication are used to manage chronic obstructive pulmonary disease (COPD): long‐acting beta₂‐agonists (LABA); long‐acting muscarinic antagonists (LAMA); and inhaled corticosteroids (ICS). To encourage patient adherence, two classes of medication are often combin...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Cochrane Database Syst Rev
Huvudupphovsmän: Sliwka, Agnieszka, Jankowski, Milosz, Gross‐Sondej, Iwona, Storman, Monika, Nowobilski, Roman, Bala, Malgorzata M
Materialtyp: Artigo
Språk:Inglês
Publicerad: John Wiley & Sons, Ltd 2018
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6513478/
https://ncbi.nlm.nih.gov/pubmed/30141826
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD012355.pub2
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk